All News #Library
Biotech
HTD1801 Shows 52-Week Efficacy in Ph3 Type 2 Diabetes Trials
31 Oct 2025 //
PHARMIWEB
Hightide Therapeutics Presents Phase 3 Data for Type 2 Diabetes
17 Sep 2025 //
PHARMAWEB

Market Place
Sourcing Support